Xylazine: A Skin Rotting Drug

Xylazine, a new drug that is horrifying US citizens with its catastrophic effects, is also called the "Zombie Drug."

Xylazine which is also known as "Tranq" or "Zombie drug". It is a new drug that is sold on the streets of Philadelphia. With its devastating effects, it is causing havoc in important cities all around the nation. This drug can actually cause the user's skin to deteriorate.

Recently, it has been discovered that Fentanyl, an opiate and Xylazine are combined to create Tranq. Xylazine was approved by the Food and Drug Administration for veterinary use, it is a sedative used on horses and cows and is not safe for humans and those who overdose on the drug do not respond to the common overdose reversal treatment naloxone or "Narcan".

This drug causes symptoms like semi-consciousness, excessive sleepiness, respiratory depression, and crusty ulcerations that can become dead skin called Eschar, which could lead to amputation if left untreated. The psychoactive effects of substances are enhanced when combined with xylazine, boosting the enjoyment of drug use.

Public health experts are concerned by its spread and worry about the horrific wounds it causes in its users' bodies. Since "tranq" is not classified as a prohibited substance for either human or animals, leaving it in a confusing and terrifying grey area, hospitals rarely test for it using standard toxicology testing.

“Tranq is basically zombifying people's bodies. Until nine months ago, I never had wounds. Now, there are holes in my legs and feet," a 28-year-old young man named Sam told Sky News

“I’d wake up in the morning crying because my arms were dying,” Tracey McCann, 39, told the New York Times.

 “The main concern is we’re already amid the worst overdose crisis in history, nationally and locally,” Dr Tsai told the Los Angeles Times.

“It’s possible that it’s more out there,” warned Dr Tsai.

Tags : #editorspick #Xylazine #tranq #zombiedrug #fentanyl #opiate #US #eschar #smitakumar #medicircle

Related Stories

Loading Please wait...


Trending Now

Why are key populations on the blindspot in the global HIV response?July 20, 2024
Exploring the Link Between Tinnitus and Body Composition: What Recent Research RevealsJuly 20, 2024
Surge in Brain Infections in India During Monsoon: A Growing ConcernJuly 20, 2024
We have more infection-prevention options now but are they actual choices for the people?July 19, 2024
New humidity-driven membrane to remove carbon dioxide from the airJuly 19, 2024
Introducing the World's First Consent-Based Data-Sharing Framework Built on Open Standards: The Affinidi Iota Framework July 19, 2024
The Power of Green Spaces: Evidence That Parks May Delay Cognitive DeclineJuly 19, 2024
Strengthening Healthcare in India: The Push for Better Coverage with Ayushman BharatJuly 19, 2024
SARV Events & Celebrations Shines at "Edu-Bizz Leadership Summit & Awards 24July 18, 2024
UAE launches global initiative to build 10 hospitals to address critical healthcare gaps as part of Zayed Humanitarian Legacy InitiativeJuly 18, 2024
Geetanjali Homestate Expands Global Presence with the Launch of Geetanjali GlobalJuly 18, 2024
Changes projected in marine fish communities due to climate changeJuly 18, 2024
Understanding the Chandipura Virus Outbreak in Gujarat: A Critical OverviewJuly 18, 2024
Landmark Study Links Severe Endometriosis to Increased Risk of Ovarian CancerJuly 18, 2024
Equipping Healthcare Professionals for Global Opportunities: GIMS Partners with NSDCJuly 18, 2024
Hormone Modulating Therapy for Breast Cancer and Its Link to Lower Alzheimer’s RiskJuly 18, 2024
Multipl Secures $1.5 Million in Additional Funds, Led by Blume Ventures and MIXI Global Investments, JapanJuly 17, 2024
FedEx to empower youth with digital skilling programJuly 17, 2024
Putting people first means following Gandhi's TalismanJuly 17, 2024
American Oncology Institute (AOI) Launches #BreaktheHabit Campaign to Raise Awareness on Head & Neck cancerJuly 17, 2024